PPAR and Pain (Q37553185)

21 August 2017

1 reference

title

PPAR and Pain (English)

1 reference

21 August 2017

Takehiko Maeda

1

0 references

author name string

Shiroh Kishioka

series ordinal

2

1 reference

21 August 2017

publication date

1 January 2009

1 reference

International Review of Neurobiology

21 August 2017

published in

1 reference

21 August 2017

volume

85

1 reference

21 August 2017

page(s)

165-177

1 reference

Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Activation of peroxisome proliferator-activated receptor alpha in rat spinal cord after peripheral noxious stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Peroxisome proliferator-activated receptors (PPARs) and peroxisomes in rat cortical and cerebellar astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

PPAR-gamma: therapeutic target for ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-alpha) in the development of inflammatory bowel disease in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

The role of the peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in the regulation of acute inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Emerging roles of PPARs in inflammation and immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Oxidized phospholipids activate PPARα in a phospholipase A2-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

The PPARalpha-leukotriene B4 pathway to inflammation control.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Peroxisome proliferator-activated receptors: insight into multiple cellular functions

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

PPARs and the complex journey to obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

A Truncated Human Peroxisome Proliferator-Activated Receptor Splice Variant with Dominant Negative Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Distinct functional types of macrophage in dorsal root ganglia and spinal nerves proximal to sciatic and spinal nerve transections in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, accelerates gastric ulcer healing in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Pioglitazone attenuates tactile allodynia and thermal hyperalgesia in mice subjected to peripheral nerve injury

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

The role of focal nerve ischemia and Wallerian degeneration in peripheral nerve injury producing hyperesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Inhibition of fatty acid amide hydrolase produces PPAR-alpha-mediated analgesia in a rat model of inflammatory pain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

The neuropathic pain triad: neurons, immune cells and glia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

PPAR gamma ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Degeneration and regeneration of the peripheral nervous system: from Augustus Waller's observations to neuroinflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Focal peripheral nerve injury induces leukocyte trafficking into the central nervous system: potential relationship to neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Crystal structure of the ligand binding domain of the human nuclear receptor PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Peroxisome proliferator-activated receptor gamma and metabolic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2985013-7

7 January 2021

10.1016/S0074-7742(09)85013-7

Identifiers

DOI

1 reference

21 August 2017

1 reference